Tissue Diagnostics: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Intended Readership
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Introduction

Chapter 3 Market Landscape

COVID-19 Global Pandemic
Coronavirus Disease 2019 Testing Basics
Diagnostic Tests with Alternative Options
Molecular Diagnostic Tests
Increasing Access to Testing
Antigen Tests
Antibody (Serology) Tests
In Vitro Diagnostic Testing EUAs

• Diagnostic Tests
• Serology/Antibody Tests
• Tests for the Management of COVID-19 Patients

Market Overview and Segmentation
Key Findings
Factors Influencing the Global Market for Tissue Diagnostics

• Drivers
• Challenges

Regulatory Landscape

• IVD Regulations in North America
• IVD Regulations in Europe
• IVD Regulations in Asia-Pacific
• IVD Regulations in Rest of the World

Chapter 4 Global Market for Tissue Diagnostics by Type of Test

Tissue Diagnostics

• Trends in the Tissue Diagnostic Test Segments
• Blood Culture
• General Cultures (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)
• Identification and Antibiotic Susceptibility Testing (ID/AST)

FDA Product Approvals in 2020

Chapter 5 Global Market for Tissue Diagnostics by Application

Oncology
Tissue Typing
Pathogen Detection

Chapter 6 Global Market for Tissue Diagnostics by Region

Introduction
North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Western Europe

• Russia
• Poland
• Turkey
• Greece
• Czech Republic
• Rest of Central and Eastern Europe

Asia-Pacific

• Key Growth Drivers
• China
• India
• Japan
• South Korea
• Australia
• Taiwan
• Rest of Asia-Pacific

Rest of the World

Chapter 7 Global Market for Tissue Diagnostics by End User/End Use

End Users/End Uses
Professional Laboratories
Emergency Care/Bed Side/OTC/Self-testing

Chapter 8 Competitive Landscape

Market Share Analysis
Mergers and Acquisitions
Product Approvals

Chapter 9 Company Profiles

ABBOTT DIAGNOSTICS INC.
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER (PART OF DANAHER)
BECTON DICKINSON AND CO.
BIOMERIEUX
Bio-Rad
GENERAL ELECTRIC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
MERCK KGAA
ORTHO CLINICAL DIAGNOSTICS
QIAGEN N.V.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC

Chapter 10 Appendix: Market Participants and List of Acronyms

Market Participants in Tissue Diagnostics
List of Acronyms

List of Tables

Summary Table A : Global Market for Tissue Diagnostics, by Region, Through 2026
Summary Table B : Global Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 1 : Total COVID-19 Cases and Deaths, by WHO Region/Country, August 9, 2021
Table 2 : Different Types of Coronavirus Tests, 2020
Table 3 : Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2, Feb. 1, 2021
Table 4 : Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2, Feb. 1, 2021
Table 5 : Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Feb. 1, 2021
Table 6 : Individual EUAs for Serology Tests for SARS-CoV-2, Feb. 1, 2021
Table 7 : Individual EUAs for IVDs for the Management of COVID-19 Patients, Feb. 1, 2021
Table 8 : Types of Diagnostic Tests and How They are Regulated
Table 9 : Changes in IVD Regulations in Asia-Pacific, 2020
Table 10 : Global Market for Tissue Diagnostics for Blood Culture, by Region, Through 2026
Table 11 : Global Market for Tissue Diagnostics for General Cultures, by Region, Through 2026
Table 12 : Global Market for Tissue Diagnostics for ID/AST, by Region, Through 2026
Table 13 : FDA Bacteriology Products Approved in 2020
Table 14 : FDA Virology Products Approved in 2020
Table 15 : Global Market for Tissue Diagnostics, by Application, Through 2026
Table 16 : Global Market for Tissue Diagnostics in Oncology, by Region, Through 2026
Table 17 : Global Market for Tissue Diagnostics for Tissue Typing, by Region, Through 2026
Table 18 : Global Market for Tissue Diagnostics for Pathogen Detection, by Region, Through 2026
Table 19 : Global Market for Tissue Diagnostics, by Region, Through 2026
Table 20 : North American Market for Tissue Diagnostics, by Country, Through 2026
Table 21 : North American Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 22 : North American Market for Tissue Diagnostics, by Application, Through 2026
Table 23 : North American Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 24 : U.S. Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 25 : U.S. Market for Tissue Diagnostics, by Application, Through 2026
Table 26 : U.S. Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 27 : Canadian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 28 : Canadian Market for Tissue Diagnostics, by Application, Through 2026
Table 29 : Canadian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 30 : Mexican Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 31 : Mexican Market for Tissue Diagnostics, by Application, Through 2026
Table 32 : Mexican Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 33 : European Market for Tissue Diagnostics, by Country, Through 2026
Table 34 : European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 35 : European Market for Tissue Diagnostics, by Application, Through 2026
Table 36 : European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 37 : Rising Geriatric Population in Germany, 2000-2030
Table 38 : Healthcare Expenditures in Germany, 2016-2020
Table 39 : German Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 40 : German Market for Tissue Diagnostics, by Application, Through 2026
Table 41 : German Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 42 : U.K. Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 43 : U.K. Market for Tissue Diagnostics, by Application, Through 2026
Table 44 : U.K. Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 45 : Healthcare Spending and Financing in France, 2005-2020
Table 46 : French Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 47 : French Market for Tissue Diagnostics, by Application, Through 2026
Table 48 : French Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 49 : Spanish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 50 : Spanish Market for Tissue Diagnostics, by Application, Through 2026
Table 51 : Spanish Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 52 : Italian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 53 : Italian Market for Tissue Diagnostics, by Application, Through 2026
Table 54 : Italian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 55 : Rest of Western European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 56 : Rest of Western European Market for Tissue Diagnostics, by Application, Through 2026
Table 57 : Rest of Western European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 58 : Russian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 59 : Russian Market for Tissue Diagnostics, by Application, Through 2026
Table 60 : Russian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 61 : Polish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 62 : Polish Market for Tissue Diagnostics, by Application, Through 2026
Table 63 : Polish Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 64 : Turkish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 65 : Turkish Market for Tissue Diagnostics, by Application, Through 2026
Table 66 : Turkish Market for Tissue Diagnostics, by End User/End Use/End Use, Through 2026
Table 67 : Greek Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 68 : Greek Market for Tissue Diagnostics, by Application, Through 2026
Table 69 : Greek Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 70 : Czech Republic Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 71 : Czech Republic Market for Tissue Diagnostics, by Application, Through 2026
Table 72 : Czech Republic Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 73 : Rest of Central and Eastern European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 74 : Rest of Central and Eastern European Market for Tissue Diagnostics, by Application, Through 2026
Table 75 : Rest of Central and Eastern European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 76 : Asia-Pacific Market for Tissue Diagnostics, by Country, Through 2026
Table 77 : Asia-Pacific Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 78 : Asia-Pacific Market for Tissue Diagnostics, by Application, Through 2026
Table 79 : Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 80 : Chinese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 81 : Chinese Market for Tissue Diagnostics, by Application, Through 2026
Table 82 : Chinese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 83 : Indian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 84 : Indian Market for Tissue Diagnostics, by Application, Through 2026
Table 85 : Indian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 86 : Forecast Japanese Trends in Aging Population, 2010-2040
Table 87 : Japanese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 88 : Japanese Market for Tissue Diagnostics, by Application, Through 2026
Table 89 : Japanese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 90 : South Korean Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 91 : South Korean Market for Tissue Diagnostics, by Application, Through 2026
Table 92 : South Korean Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 93 : Australian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 94 : Australian Market for Tissue Diagnostics, by Application, Through 2026
Table 95 : Australian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 96 : Taiwanese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 97 : Taiwanese Market for Tissue Diagnostics, by Application, Through 2026
Table 98 : Taiwanese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 99 : Rest of Asia-Pacific Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 100 : Rest of Asia-Pacific Market for Tissue Diagnostics, by Application, Through 2026
Table 101 : Rest of Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 102 : Rest of the World Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 103 : Rest of the World Market for Tissue Diagnostics, by Application, Through 2026
Table 104 : Rest of the World Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 105 : Global Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 106 : Global Market for Tissue Diagnostics for Professional Laboratories, by Region, Through 2026
Table 107 : Global Market for Tissue Diagnostics for Emergency Care/Bed Side/OTC/ Self-testing, by Region, Through 2026
Table 108 : Global Company Market Shares of Tissue Diagnostics, 2020
Table 109 : Diagnostic Manufacturer Mergers and Acquisitions, 2016-2021
Table 110 : U.S. FDA Approvals of High-Complexity IVD Products, 2019-2020
Table 111 : Abbott Laboratories: Key Developments, 2021
Table 112 : Beckman Coulter: Key Developments, 2021
Table 113 : BD: Key Developments, 2021
Table 114 : bioMeriux: Key Developments, 2021
Table 115 : Bio-Rad: Key Developments, 2021
Table 116 : General Electric: Financials, 2019
Table 117 : GE Healthcare: Product Portfolio
Table 118 : GE Healthcare: Recent Developments, 2021
Table 119 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 120 : F. Hoffmann-La Roche Ltd.: Revenues, by Segment, 2016-2018
Table 121 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 122 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 123 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2021
Table 124 : Hologic: Product Portfolio
Table 125 : Hologic: Financials, 2018-2020
Table 126 : Hologic: Key Developments, 2021
Table 127 : Siemens Healthineers AG: Key Products
Table 128 : Siemens Healthineers AG: Product Segments
Table 129 : Siemens Healthineers AG: Financials, 2019
Table 130 : Siemens Healthineers AG: Key Developments, 2021
Table 131 : Thermo Fisher Scientific Inc.: Financials, 2018 and 2019
Table 132 : Thermo Fisher Scientific Inc.: Products and Services
Table 133 : Thermo Fisher Scientific Inc.: Key Developments, 2021

List of Figures

Summary Figure A : Global Market for Tissue Diagnostics, by Region, 2018-2026
Summary Figure B : Global Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 1 : Global Market for Tissue Diagnostics, by Type, 2018-2026
Figure 2 : Global Market Shares of Clinical Microbiology Tests, by Type, 2020
Figure 3 : Global Market for Tissue Diagnostics for Blood Culture, by Region, 2018-2026
Figure 4 : Global Market for Tissue Diagnostics for General Cultures, by Region, 2018-2026
Figure 5 : Global Market for Tissue Diagnostics for ID/AST, by Region, 2018-2026
Figure 6 : Global Market for Tissue Diagnostics, by Application, 2018-2026
Figure 7 : Global Market Shares of Tissue Diagnostics, by Application, 2020
Figure 8 : Global Market for Tissue Diagnostics in Oncology, by Region, 2018-2026
Figure 9 : Global Market for Tissue Diagnostics for Tissue Typing, by Region, 2018-2026
Figure 10 : Global Market for Tissue Diagnostics for Pathogen Detection, by Region, 2018-2026
Figure 11 : Global Market for Tissue Diagnostics, by Region, 2018-2026
Figure 12 : North American Market for Tissue Diagnostics, by Country, 2018-2026
Figure 13 : North American Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 14 : North American Market for Tissue Diagnostics, by Application, 2018-2026
Figure 15 : North American Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 16 : U.S. Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 17 : U.S. Market for Tissue Diagnostics, by Application, 2018-2026
Figure 18 : U.S. Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 19 : Canadian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 20 : Canadian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 21 : Canadian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 22 : Mexican Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 23 : Mexican Market for Tissue Diagnostics, by Application, 2018-2026
Figure 24 : Mexican Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 25 : European Market for Tissue Diagnostics, by Country, 2018-2026
Figure 26 : European Market for Tissue Diagnostics, by Country, 2018-2026
Figure 27 : European Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 28 : European Market for Tissue Diagnostics, by Application, 2018-2026
Figure 29 : European Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 30 : Rising Geriatric Population in Germany, 2000-2030
Figure 31 : Healthcare Expenditures in Germany, 2016-2020
Figure 32 : German Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 33 : German Market for Tissue Diagnostics, by Application, 2018-2026
Figure 34 : German Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 35 : U.K. Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 36 : U.K. Market for Tissue Diagnostics, by Application, 2018-2026
Figure 37 : U.K. Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 38 : Healthcare Spending and Financing in France, 2005-2020
Figure 39 : French Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 40 : French Market for Tissue Diagnostics, by Application, 2018-2026
Figure 41 : French Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 42 : Spanish Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 43 : Spanish Market for Tissue Diagnostics, by Application, 2018-2026
Figure 44 : Spanish Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 45 : Italian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 46 : Italian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 47 : Italian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 48 : Rest of Western European Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 49 : Rest of Western European Market for Tissue Diagnostics, by Application, 2018-2026
Figure 50 : Rest of Western European Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 51 : Russian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 52 : Russian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 53 : Russian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 54 : Polish Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 55 : Polish Market for Tissue Diagnostics, by Application, 2018-2026
Figure 56 : Polish Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 57 : Turkish Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 58 : Turkish Market for Tissue Diagnostics, by Application, 2018-2026
Figure 59 : Turkish Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 60 : Greek Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 61 : Greek Market for Tissue Diagnostics, by Application, 2018-2026
Figure 62 : Greek Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 63 : Czech Republic Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 64 : Czech Republic Market for Tissue Diagnostics, by Application, 2018-2026
Figure 65 : Czech Republic Market for Tissue Diagnostic Testing, by End User/End Use, 2018-2026
Figure 66 : Rest of Central and Eastern European Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 67 : Rest of Central and Eastern European Market for Tissue Diagnostics, by Application, 2018-2026
Figure 68 : Rest of Central and Eastern European Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 69 : Asia-Pacific Market for Tissue Diagnostics, by Country, 2018-2026
Figure 70 : Asia-Pacific Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 71 : Asia-Pacific Market for Tissue Diagnostics, by Application, 2018-2026
Figure 72 : Asia-Pacific Market for Tissue Diagnostics, by Application, 2018-2026
Figure 73 : Chinese Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 74 : Chinese Market for Tissue Diagnostics, by Application, 2018-2026
Figure 75 : Chinese Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 76 : Indian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 77 : Indian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 78 : Indian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 79 : Forecast Japanese Trends in Aging Population, 2010-2040
Figure 80 : Japanese Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 81 : Japanese Market for Tissue Diagnostics, by Application, 2018-2026
Figure 82 : Japanese Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 83 : South Korean Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 84 : South Korean Market for Tissue Diagnostics, by Application, 2018-2026
Figure 85 : South Korean Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 86 : Australian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 87 : Australian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 88 : Australian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 89 : Taiwanese Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 90 : Taiwanese Market for Tissue Diagnostics, by Application, 2018-2026
Figure 91 : Taiwanese Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 92 : Rest of Asia-Pacific Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 93 : Rest of Asia-Pacific Market for Tissue Diagnostics, by Application, 2018-2026
Figure 94 : Rest of Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 95 : Rest of the World Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 96 : Rest of the World Market for Tissue Diagnostics, by Application, 2018-2026
Figure 97 : Rest of the World Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 98 : Global Market Shares of Tissue Diagnostics, by End User/End Use, 2020
Figure 99 : Global Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 100 : Global Market for Tissue Diagnostics for Professional Laboratories, by Region, 2018-2026
Figure 101 : Global Market for Tissue Diagnostics for Emergency Care/Bed Side/OTC/ Self-testing, by Region, 2018-2026
Figure 102 : Global Company Market Shares of Tissue Diagnostics, 2020
Figure 103 : GE Healthcare: Revenue Share, by Region/Country, 2019
Figure 104 : GE Healthcare: Revenue Share, by Business Segment, 2019
Figure 105 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 106 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Geography, 2019
Figure 107 : Siemens Healthineers AG: Revenue Share, by Business Segment, 2019
Figure 108 : Siemens Healthineers AG: Revenue Share, by Region, 2019
Figure 109 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2019

当レポートのプレスリリースは発行されておりません。